Filters close
Released: 23-Feb-2023 10:10 AM EST
Emory University’s Matthew Reyna Research Team Wins $50,000 FASEB DataWorks! Prize
Federation of American Societies for Experimental Biology (FASEB)

Matthew Reyna, PhD, Assistant Professor in the Department of Biomedical Informatics and the Department of Pharmacology and Chemical Biology at Emory University, received the FASEB DataWorks! Prize Distinguished Achievement Award.

Released: 23-Feb-2023 10:05 AM EST
MIT’s Leo Anthony Celi Leads Research Team to Win $12,500 FASEB DataWorks! Prize
Federation of American Societies for Experimental Biology (FASEB)

Leo Anthony Celi, PhD, is among the winners of the FASEB DataWorks! Prize. The Prize, a partnership between the Federation of American Societies for Experimental Biology and National Institutes of Health, recognizes research teams that integrate data sharing and reuse to advance human health.

   
Released: 23-Feb-2023 10:05 AM EST
George Mason University’s Giorgio Ascoli Leads Research Team to Win $50,000 FASEB DataWorks! Prize
Federation of American Societies for Experimental Biology (FASEB)

Giorgio Ascoli, PhD, is among the winners of the FASEB DataWorks! Prize. The Prize, a partnership between the Federation of American Societies for Experimental Biology and National Institutes of Health, recognizes research teams that integrate data sharing and reuse to advance human health.

   
Released: 23-Feb-2023 10:05 AM EST
The Rockefeller University’s Erich Jarvis Leads Research Team to Win $50,000 FASEB DataWorks! Prize
Federation of American Societies for Experimental Biology (FASEB)

Erich Jarvis, PhD, is among the winners of the FASEB DataWorks! Prize. The Prize, a partnership between the Federation of American Societies for Experimental Biology and National Institutes of Health, recognizes research teams that integrate data sharing and reuse to advance human health.

   
Released: 23-Feb-2023 10:05 AM EST
University of Colorado’s Melissa Haendel Leads Research Team to Win $100,000 FASEB DataWorks! Prize
Federation of American Societies for Experimental Biology (FASEB)

Melissa Haendel, PhD, is among the winners of the FASEB DataWorks! Prize. The Prize, a partnership between the Federation of American Societies for Experimental Biology and National Institutes of Health, recognizes research teams that integrate data sharing and reuse to advance human health.

   
Released: 23-Feb-2023 10:05 AM EST
University of Colorado’s Monica Munoz-Torres Leads Research Team to Win $50,000 FASEB DataWorks! Prize
Federation of American Societies for Experimental Biology (FASEB)

Monica Munoz-Torres, PhD, is among the winners of the FASEB DataWorks! Prize. The Prize, a partnership between the Federation of American Societies for Experimental Biology and National Institutes of Health, recognizes research teams that integrate data sharing and reuse to advance human health.

   
Released: 23-Feb-2023 10:05 AM EST
University of Colorado’s Arjun Krishnan Leads Research Team to Win $12,500 FASEB DataWorks! Prize
Federation of American Societies for Experimental Biology (FASEB)

Arjun Krishnan, PhD, is among the winners of the FASEB DataWorks! Prize. The Prize, a partnership between the Federation of American Societies for Experimental Biology and National Institutes of Health, recognizes research teams that integrate data sharing and reuse to advance human health.

   
Released: 23-Feb-2023 10:05 AM EST
Allen Institute’s Michael Hawrylycz Leads Research Team to Win $25,000 FASEB DataWorks! Prize
Federation of American Societies for Experimental Biology (FASEB)

Michael Hawrylycz, PhD, is among the winners of the FASEB DataWorks! Prize. The Prize, a partnership between the Federation of American Societies for Experimental Biology and National Institutes of Health, recognizes research teams that integrate data sharing and reuse to advance human health.

   
Released: 23-Feb-2023 9:50 AM EST
Stanford University’s Luca Pegolotti Leads Research Team to Win $12,500 FASEB DataWorks! Prize
Federation of American Societies for Experimental Biology (FASEB)

Luca Pegolotti, PhD, is among the winners of the FASEB DataWorks! Prize. The Prize, a partnership between the Federation of American Societies for Experimental Biology and National Institutes of Health, recognizes research teams that integrate data sharing and reuse to advance human health.

   
Released: 21-Feb-2023 11:00 AM EST
FASEB and NIH Announce DataWorks! Prize Winners
Federation of American Societies for Experimental Biology (FASEB)

FASEB and NIH select inaugural winners of the DataWorks! Prize, showcasing research teams' exemplary data sharing and reuse projects.

Released: 31-Jan-2023 11:05 AM EST
Announcing 2022 FASEB BioArt Awards
Federation of American Societies for Experimental Biology (FASEB)

FASEB BioArt Award winners capture the beauty of biological and biomedical research.

Newswise: New Resource Helps Researchers Manage Data, Ease Research Process
Released: 10-Jan-2023 12:10 PM EST
New Resource Helps Researchers Manage Data, Ease Research Process
Federation of American Societies for Experimental Biology (FASEB)

FASEB continues its efforts to facilitate a culture of scientific data sharing and reuse by launching DataWorks! Help Desk.

Newswise: ASPET Ends Page Charges for Open Access Articles in Journals
Released: 20-Dec-2022 5:35 PM EST
ASPET Ends Page Charges for Open Access Articles in Journals
Federation of American Societies for Experimental Biology (FASEB)

The American Society for Pharmacology and Experimental Therapeutics, a FASEB member society, will end page charges for new submissions from all authors who opt-in for Open Access.

Newswise: Dr. Loretta Doan Named Chief Executive Officer of The American Association of Immunologists
Released: 16-Dec-2022 9:00 AM EST
Dr. Loretta Doan Named Chief Executive Officer of The American Association of Immunologists
Federation of American Societies for Experimental Biology (FASEB)

The American Association of Immunologists announces the appointment of Loretta Doan, PhD, as its new Chief Executive Officer.

   
Newswise: The Journal of Pharmacology and Experimental Therapeutics Launches Editorial Fellowship Program
Released: 12-Dec-2022 4:30 PM EST
The Journal of Pharmacology and Experimental Therapeutics Launches Editorial Fellowship Program
Federation of American Societies for Experimental Biology (FASEB)

The Journal of Pharmacology and Experimental Therapeutics (JPET) is launching a one-year Editorial Fellowship Program.

Newswise: The American Association of Immunologists Announces 2022 Recipients of the Travel for Techniques Awards Program
Released: 29-Nov-2022 5:10 PM EST
The American Association of Immunologists Announces 2022 Recipients of the Travel for Techniques Awards Program
Federation of American Societies for Experimental Biology (FASEB)

The American Association of Immunologists, a FASEB member society, supports scientists’ career development by providing travel awards to those interested in traveling to learn techniques needed for their research.

Released: 18-Nov-2022 10:30 AM EST
FASEB Joins ORCID Community to Advance Open Science and Research Integrity
Federation of American Societies for Experimental Biology (FASEB)

FASEB joins the ORCID US Community, a consortium of nonprofit institutions working to advance open science and research integrity.

   
Newswise: The American Association of Immunologists Announces 2022 Recipients of the Careers in Immunology Fellowships
Released: 31-Oct-2022 12:45 PM EDT
The American Association of Immunologists Announces 2022 Recipients of the Careers in Immunology Fellowships
Federation of American Societies for Experimental Biology (FASEB)

The American Association of Immunologists, a FASEB member society, supports the career development of young scientists by providing eligible principal investigators with one year of salary support for a trainee in their labs.

Released: 10-Oct-2022 9:00 AM EDT
FASEB Seeks Nominations for Excellence in Science Awards
Federation of American Societies for Experimental Biology (FASEB)

FASEB is now accepting nominations for its 2023 Excellence in Science Awards.

Newswise: FASEB Joins Alliance in Support of Open Scholarship
Released: 27-Sep-2022 12:10 PM EDT
FASEB Joins Alliance in Support of Open Scholarship
Federation of American Societies for Experimental Biology (FASEB)

FASEB joins alliance of organizations to identify, articulate, and advance open science, open data, and open scholarship norms and practices within their disciplines.

Released: 9-Sep-2022 12:40 PM EDT
FASEB Announces 2022 Excellence in Science Award Recipients
Federation of American Societies for Experimental Biology (FASEB)

FASEB Excellence in Science Awards showcase outstanding achievements of women in the biological and biomedical sciences.

   
25-Mar-2022 9:00 AM EDT
Study Reveals the Science Behind Those Irresistible Puppy-Dog Eyes
Federation of American Societies for Experimental Biology (FASEB)

Can’t resist your pup’s adoring expression when he begs for a treat? A new study reveals key anatomical features that could explain what makes dogs’ faces so appealing. The findings also suggest that humans contributed to dogs’ ability to form facial expressions through thousands of years of selective breeding.

25-Mar-2022 9:00 AM EDT
Study Reveals How Deadly Tick Disease Spreads
Federation of American Societies for Experimental Biology (FASEB)

Findings from a new study are providing important insights into the spread of Rocky Mountain spotted fever, which is transmitted from dogs to people through ticks. The new data are being used to create models that could help predict, and possibly prevent, future outbreaks.

25-Mar-2022 9:00 AM EDT
Researchers Uncover How Sugar Substitutes Disrupt Liver Detoxification
Federation of American Societies for Experimental Biology (FASEB)

Results from a new study suggest that two sugar substitutes disrupt the function of a protein that plays a vital role in liver detoxification and the metabolism of certain drugs. These sugar substitutes, also known as non-nutritive sweeteners, provide a sweet taste with few or no calories.

25-Mar-2022 9:00 AM EDT
Vitamin K Shows Evidence of Brain Benefits in Rats
Federation of American Societies for Experimental Biology (FASEB)

In a new study conducted in rats, scientists report evidence that vitamin K could help protect against aging-related cognitive declines associated with Alzheimer’s disease and other forms of dementia.

25-Mar-2022 9:00 AM EDT
Diagnosing Sports-Related Concussions May Be Harder than Previously Thought
Federation of American Societies for Experimental Biology (FASEB)

In a new study, many athletes reported symptoms that are often used to diagnose concussions even though they did not suffer a head injury. The findings suggest that some symptoms, such as fatigue and neck pain, could be attributed to intense exercise rather than a brain injury.

25-Mar-2022 9:00 AM EDT
Gut Bacteria May Contribute to Blood Pressure Medicine Resistance
Federation of American Societies for Experimental Biology (FASEB)

Almost half of the U.S. adult population has high blood pressure — or hypertension — and about 20% of these patients have treatment-resistant hypertension. The reason why some people are resistant to treatment has been a mystery, but new study results show that a certain gut bacterium may be an important factor.

25-Mar-2022 9:00 AM EDT
Autism-Associated Brain Differences Can Be Observed in the Womb
Federation of American Societies for Experimental Biology (FASEB)

A new study using prenatal brain scans revealed significant differences in brain structures at around 25 weeks’ gestation between children who were later diagnosed with ASD and those who were not. The study adds to mounting evidence that autism begins in early development and suggests possible opportunities to identify the disorder at an earlier age.

25-Mar-2022 9:00 AM EDT
Proteins in Saliva Could Aid in COVID-19 Detection and Predict Severe Illness
Federation of American Societies for Experimental Biology (FASEB)

Researchers have identified a family of proteins that is significantly elevated in the saliva of patients hospitalized with COVID-19. The proteins, known as ephrin ligands, could potentially serve as a biomarker to help doctors identify patients who are at risk for serious illness.

25-Mar-2022 9:00 AM EDT
Scientists Identify Cancer Biomarkers in Breast Milk
Federation of American Societies for Experimental Biology (FASEB)

A simple blood test for women of all ages and risk levels could one day be possible thanks to a new set of protein biomarkers that researchers identified using breast milk.

25-Mar-2022 9:00 AM EDT
Vitamin C Could Help Reduce Toxic Side Effects of Common Cancer Treatment
Federation of American Societies for Experimental Biology (FASEB)

A study conducted in rats suggests that taking vitamin C may help to counteract the muscle atrophy that is a common side effect of the chemotherapy drug doxorubicin. Although clinical studies would be needed to determine the safety and effectiveness of taking vitamin C during doxorubicin treatment, the findings suggest vitamin C may represent a promising opportunity to reduce some of the drug’s most debilitating side effects.

25-Mar-2022 9:00 AM EDT
Scientists Uncover Why Long COVID Can Cause Pain
Federation of American Societies for Experimental Biology (FASEB)

A new animal study has provided important insights into how COVID-19 SARS-CoV-2 — the virus responsible for COVID-19 — can lead to long-term pain. The new findings also point to a potential therapy for COVID-related pain.

25-Mar-2022 9:00 AM EDT
Animal Study Shows Safety of Using CBD and THC with Opioids
Federation of American Societies for Experimental Biology (FASEB)

Findings from a new animal study suggest that cannabidiol (CBD) and tetrahydrocannabinol (THC) might be safe for use with opioid pain relievers. Although more studies are needed, the results suggest that these compounds might be a low-risk way to reduce the dose of opioids needed to relieve pain.

25-Mar-2022 9:00 AM EDT
Exercise Could Help Reduce Severity of Serious Cancer Complication
Federation of American Societies for Experimental Biology (FASEB)

A new study has identified yet another benefit of keeping up your exercise routine. In experiments performed with mice, researchers found that exercising prior to developing cancer was associated with slower tumor growth and helped reduce the effects of a cancer complication known as wasting syndrome, or cachexia.

25-Mar-2022 9:00 AM EDT
Cardamonin Shows Promise for Treating Aggressive Breast Cancer
Federation of American Societies for Experimental Biology (FASEB)

Cardamonin — a natural compound found in the spice cardamom and other plants — could have therapeutic potential for triple-negative breast cancer, according to a new study using human cancer cells. The findings also show that the compound targets a gene that helps cancer cells elude the immune system.

25-Mar-2022 9:00 AM EDT
Mineral Supplement Could Stop Fatty Liver Disease Progression
Federation of American Societies for Experimental Biology (FASEB)

Results from a preclinical study add new evidence that a multi-mineral dietary supplement known as Aquamin could be a simple and effective way to reduce the long-term health consequences of non-alcoholic fatty liver disease. Aquamin, which is derived from calcified red marine algae, is rich in calcium, magnesium and 72 other minerals and trace elements.

25-Mar-2022 9:00 AM EDT
Yo-Yo Dieting and Food Insecurity May Raise Heart Disease Risk
Federation of American Societies for Experimental Biology (FASEB)

Fluctuations in body weight resulting from drastically cutting and increasing calories may lead to physiological changes that raise the risk of heart disease or diabetes later in life, according to a study being presented at the American Physiological Society annual meeting during the Experimental Biology (EB) 2022 meeting, held in Philadelphia April 2–5.

25-Mar-2022 9:00 AM EDT
Researchers Harness Probiotics to Deliver Parkinson’s Disease Treatment
Federation of American Societies for Experimental Biology (FASEB)

Researchers have engineered probiotic bacteria that can synthesize the dopamine precursor L-DOPA, a powerful mainstay treatment for Parkinson’s disease. Preclinical tests show that the new treatment approach is not only safe and well-tolerated but also eliminates side effects that eventually develop when L-DOPA is taken orally.

25-Mar-2022 9:00 AM EDT
Plant Compound Shows Promise for Alleviating Food Allergies
Federation of American Societies for Experimental Biology (FASEB)

Researchers combined advanced computational methods with experimental studies to gain new insight, at the cell level, into how the plant compound formononetin might be used to treat food allergies. With nearly 10% of the world population affected by food allergies — which are sometimes life-threatening — new treatments are critically needed.

25-Mar-2022 9:00 AM EDT
Omega-3s Could Boost Immunotherapy’s Cancer-Fighting Power
Federation of American Societies for Experimental Biology (FASEB)

Findings from a new study performed in mice suggest that omega-3 fatty acids could help immunotherapy and other treatments do a better job at fighting cancer. Immunotherapies, which stimulate the body’s own immune system to attack cancer, have revolutionized cancer treatment, but they don’t work for every patient.

25-Mar-2022 9:00 AM EDT
COVID-19 Vaccine-Associated Menstrual Symptoms Reported in Non-Menstruating People
Federation of American Societies for Experimental Biology (FASEB)

Many people who do not usually menstruate reported experiencing breakthrough bleeding or other period symptoms after receiving a COVID-19 vaccine, according to new findings from an online survey by researchers at Washington University in St. Louis.

Released: 25-Mar-2022 9:30 AM EDT
Experimental Biology 2022 Press Materials Available Now
Federation of American Societies for Experimental Biology (FASEB)

Embargoed press materials are now available for the Experimental Biology (EB) 2022 meeting, featuring cutting-edge research from across the life sciences. EB 2022, to be held April 2–5 in Philadelphia, is the annual meeting of five scientific societies bringing together thousands of scientists and 25 guest societies in one interdisciplinary community.

Released: 25-Mar-2022 9:00 AM EDT
Announcing Virtual Press Conference for Experimental Biology 2022 Meeting
Federation of American Societies for Experimental Biology (FASEB)

Reporters are invited to join a live discussion of research announcements at the forefront of the life sciences during a virtual press conference for the Experimental Biology (EB) 2022 meeting. The press conference will be held online from 11–11:45 a.m. Eastern on Friday, April 1, 2022 (RSVP by Thursday, March 31).

Released: 9-Mar-2022 9:00 AM EST
Hot Topics at Experimental Biology 2022 Meeting, April 2–5 in Philadelphia
Federation of American Societies for Experimental Biology (FASEB)

EB, the annual meeting of five scientific societies, brings together thousands of scientists and 25 guest societies in one interdisciplinary community. Join us April 2–5 in Philadelphia for an exciting lineup of live, in-person scientific sessions.

   
Released: 1-Feb-2022 9:00 AM EST
Speakers Announced for Experimental Biology 2022 Meeting
Federation of American Societies for Experimental Biology (FASEB)

Celebrated scientists and educators, including Nobel laureates and research pioneers, from across the life sciences will convene at the Experimental Biology (EB) 2022 meeting on April 2–5 in Philadelphia. EB brings together thousands of scientists to explore the latest findings and trends in anatomy, biochemistry, molecular biology, investigative pathology, pharmacology and physiology.

Released: 6-Jan-2022 9:05 AM EST
Press Registration Now Open for Experimental Biology 2022 Meeting in Philadelphia
Federation of American Societies for Experimental Biology (FASEB)

Complimentary press passes are now available for the Experimental Biology (EB) 2022 meeting, to be held April 2–5 in Philadelphia. EB is the annual meeting of five scientific societies bringing together thousands of scientists and 25 guest societies in one interdisciplinary community.

   
20-Apr-2021 9:00 AM EDT
Depression Medication Could Also Protect Against Heart Disease
Federation of American Societies for Experimental Biology (FASEB)

The antidepression drug duloxetine could be beneficial to patients with both depression and cardiovascular disease, according to new studies performed in human blood and in mice. Globally, more than 300 million people have depression, which comes with an increased risk of developing cardiovascular disease.

20-Apr-2021 9:00 AM EDT
Could Corals Use Sound to Communicate?
Federation of American Societies for Experimental Biology (FASEB)

Corals are part of a highly complex ecosystem, but it remains a mystery if and how they might communicate within their biological community. In a new study, researchers found evidence of sound-related genes in corals, suggesting that the marine invertebrates could use sound to interact with their surroundings.

20-Apr-2021 9:00 AM EDT
Potential Advancements in Treatment of PTSD and PTSD-related Cardiovascular Disease
Federation of American Societies for Experimental Biology (FASEB)

A new study reveals that renin-angiotensin system (RAS) genes within the amygdala—the brain region important for traumatic memory processing—express differently when the brain develops fearful memories, such as when people undergo traumatic stress. Researchers have found that medication may potentially be used as a pharmacological blockade of the angiotensin type 1 receptor, thereby improving components of fear memory as assessed by freezing behavior.



close
0.22033